Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients.
Valeria Maria PintoManuela BaloccoSabrina QuintinoLorenzo BacigalupoBarbara GianesinMonica RizziRoberto MalagòLucia De FranceschiGian Luca ForniPublished in: American journal of hematology (2018)